Total group = 122 patients
These associations remained consistent across subgroup analyses, including patients using tirzepatide as adjunctive therapy to other first-line diabetes agents, among patients older than 60 and comparisons against individual GLP-1 drugs, including semaglutide and dulaglutide
I trained at Vanderbilt, did my residency at Georgetown, and worked at University of Pennsylvania before settling into practice in Northeastern Pennsylvania, where Ive spent years performing general and bariatric surgeries and working with patients whove tried everything and are looking for real help
This question is asked because they utilize compounded medications, which means that the GLP-1 is combined with something else, like B-12 or L-carnitine
This is understood to extend its circulating half-life, supporting once-weekly subcutaneous administration in clinical trial protocols
Systemic inflammatory response syndrome (SIRS) following unregulated IV administration, presenting with fever above 41 degrees Celsius, acute liver injury, and clotting abnormalities, is also documented in a 2025 case report